Davis & Shirtliff Named Twice in Business Worldwide Magazine’s 2025 Global Corporate Excellence Awards

Davis & Shirtliff, one of East Africa's most influential distributors of pumps, solar power systems, and water solutions, has been honoured with two prestigious awards at the Global Corporate Excellence Awards 2025. The company won “Company of the Year – Africa: Engineering Innovation in Water & Energy Solutions” and the “Sustainability & ESG Leadership Award […]

Questex’s Chief Medical Officer Summit 360° Announces 2026 Agenda and Keynotes

NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) — Today, Questex's Chief Medical Officer Summit 360° (CMO 360°) announces the agenda and keynote speakers for the 14th annual conference uniquely designed for the biotech industry. CMO 360° takes place April 13-14 at the Fairmont Copley Plaza in Boston. Previously organized by the Conference Forum, the CMO

ImmuneWalk Therapeutics Announces Positive Results from Phase 1 SAD/MAD Study of IW-601, a First-In-Class Therapeutic with Broad Potential in Inflammatory and Autoimmune Diseases

Phase 1 Clinical Trial Met All Primary and Secondary Endpoints and Demonstrated Positive Safety, Pharmacokinetics, and Mechanistic Validation Clinical Data Build Upon Robust Preclinical Activity Seen in Multiple Models of Inflammatory Disease Novel Approach Addresses Inflammation Driven by Monocytes and Neutrophils, Key Drivers in Many Auto-Inflammatory and Auto-Immune Diseases Phase 2 Study in Behcet's Disease,

Innventure Set to Join the Russell 2000(R), Russell 3000(R), and Russell Microcap(R) Indexes

(NasdaqGM:INV),(NASDAQ:INVW), ORLANDO, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) — Innventure, Inc. (NASDAQ: INV) today announced that it has been added to the Russell 2000(R) Index and the broader Russell 3000(R) Index, effective at the open of U.S. equity markets on December 22, 2025, as part of the annual Russell indexes reconstitution. In addition, Innventure has

Cerence AI Expands Beyond the Vehicle to New Areas of the Automotive Ecosystem with Launch of AI Agents

(NASDAQ:CRNC), SUMMARY AND KEY POINTS: Cerence AI introduces new conversational AI agents for dealerships and OEMs, growing its portfolio of agentic, domain-specific solutions and expanding to new areas beyond the in-vehicle experience. The dealer assist agent empowers automotive dealerships with intelligent sales and service automation, advancing Cerence's strategy to deliver agentic AI solutions to extended

BondBloxx Releases 2026 Fixed Income Outlook

(CBOE:XEMD),(NasdaqGM:PCMM), LARKSPUR, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — BondBloxx Investment Management, a provider of precision fixed income ETFs with over $6 billion in assets, today released its 2026 Fixed Income Market Outlook providing advisors and investors with insights and investment ideas for the year ahead. “With uncertainty and market volatility expected to persist in

WALKER RIVER ANNOUNCES SIGNIFICANT GOLD INTERCEPTS AT THE LAPON CANYON GOLD PROJECT

(TSX-V:WRR), Vancouver, B.C., Dec. 11, 2025 (GLOBE NEWSWIRE) — Walker River Resources Corp. (“Walker” or the “Company“) (TSX-V: WRR) is pleased to announce additional assay results from the ongoing reverse circulation (“RC”) drill program at the Lapon Canyon portion of the Lapon Gold Project, located within Nevada's Prolific Walker Lane Gold trend, 60 km SE

Apolosign Unveils Three Family-Friendly Holiday Gifts as Americans Seek Practical, Heartwarming Tech This Season

NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) — As Americans dive into the busiest shopping season of the year, many families are seeking gifts that are both useful and meaningful. With school concerts, office parties, holiday travel, and Christmas preparations stacking up, households are looking for tech that simplifies daily life rather than adds more

zSpace Announces Strategic Restructuring to Strengthen Financial Foundation

(NASDAQ:ZSPC), SAN JOSE, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — zSpace, Inc. (NASDAQ: ZSPC), a global leader in immersive augmented reality (AR) learning solutions for education, today announced the successful completion of a comprehensive strategic restructuring designed to optimize its cost structure, enhance operational efficiency, and position the company for sustained long-term success. This initiative

Aligos Therapeutics Presents Positive Data at HEP-DART 2025

(NASDAQ:ALGS), SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced positive data from four presentations, including two oral presentations, at the HEP-DART 2025 Meeting, being held December 7 –

Scroll to Top